Latest Mitochondrial disease Stories
First subject enrolled in pivotal clinical trial MOUNTAIN VIEW, Calif., March 10, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced the initiation of a phase 2B/3 study entitled,
MitoAction and UMDF have joined together to congratulate Edison Pharmaceuticals in their announcement last week of a nearly $4.3 billion strategic partnership with Dainippon Sumitomo Pharma Co.,
EPI-743 in phase 2 development for Friedreich's ataxia MOUNTAIN VIEW, Calif., Feb.
Furthering the future of cell metabolism research in China BILLERICA, Mass., Jan.
The conference offers physicians and specialists who are not mitochondrial experts an opportunity to understand more about identifying mitochondrial diseases, managing adults and children with
Through working with tiny cell structures called mitochondria, scientists may have unlocked one of the secrets of the aging process.
Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson's disease.
Mitochondria are the power plants of cells, manufacturing chemical fuel so a cell can perform its many tasks.
- A woman chauffeur.
- A woman who operates an automobile.